|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center and Division of General Internal Medicine, Duke University, Durham, NC
2 From the Nicotine Research Laboratory, Durham Veterans Affairs Medical Center, and Department of Psychiatry, Duke University Medical Center, Durham, NC
Study objective: This study was conducted to determine if the combination of airway sensory replacement and nicotine replacement improves 10-week smoking abstinence rates over nicotine replacement alone.
Design: Double-blind, randomized, placebo-controlled trial.
Setting: Outpatient research clinic.
Participants: One hundred healthy volunteers who smoked at least one pack of cigarettes per day and desired to quit smoking.
Interventions: Subjects received either citric acid (n=41) or lactose placebo (n=59) inhalers to cope with smoking urges for 10 weeks. All subjects received self-help materials and nicotine patches for 6 weeks. Return visits were at weeks 1, 4, 6, and 10. Abstinence was defined as zero cigarettes smoked since the quit date verified by exhaled carbon monoxide
8 ppm at all return visits. Inhaler effects were measured by a standardized questionnaire.
Measurements and results: The primary outcome of continuous abstinence at the end of the 10-week treatment period was 19.5% (95% confidence interval [CI]=7.4 to 31.6%) for the citric acid group vs 6.8% (95% CI=0.4 to 13.2%) for the lactose group (p=0.05). Relief from craving and short-term abstinence increased as airway sensations from the inhaler also increased. Abstinence at 10 weeks for subjects receiving strong airway sensations from the inhalers was 33.3% (95%CI=14.5 to 52.1%). At 6 months, there was no difference in abstinence between the treatment groups (0% vs 5.1%, p=0.20).
Conclusions: When combined with the nicotine patch, the citric acid inhaler improved 10-week smoking abstinence over lactose inhaler. The combination of airway sensory replacement and nicotine replacement may prove beneficial for smoking cessation.
Key Words: citric acid nicotine patch smoking cessation
Submitted on May 9, 1994
Accepted on September 21, 2007
This article has been cited by other articles:
![]() |
A. V. Prochazka, S. Kick, C. Steinbrunn, T. Miyoshi, and G. E. Fryer A Randomized Trial of Nortriptyline Combined With Transdermal Nicotine for Smoking Cessation Arch Intern Med, November 8, 2004; 164(20): 2229 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Prochazka, M. J. Weaver, R. T. Keller, G. E. Fryer, P. A. Licari, and D. Lofaso A Randomized Trial of Nortriptyline for Smoking Cessation Arch Intern Med, October 12, 1998; 158(18): 2035 - 2039. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |